This web site will not work properly without javascript!
RxDB
References
ICD-10-CM Codes
Browse (Tabular)
Diagnostic Codes Index
External Causes Index
Table of Neoplasms
Table of Drugs
ICD-10-PCS Codes
Browse (Tables)
ICD-9-CM Codes
ICD-9-PCS Codes
MDC / MS-DRG
HCPCS
Help
About RxDB
Sitemap
Contact Us
Terms of Service
Privacy Policy
ICD-10-CM Codes
Browse (Tabular)
Diagnostic
External
Drug
Neoplasm
T39.1X5A
–
Adverse effect of 4-Aminophenol derivatives, initial encounter
Follow
Overview
Coding Notes
Active
Billable, valid for HIPAA-covered transactions
GEM Conversion to ICD-9 CM
995.29
Fs:
10111
–
Unspecified adverse effect of other drug, medicinal and biological substance
E93.53
Fs:
10112
–
Salicylates causing adverse effects in therapeutic use
MDC / MS-DRG Reference
DRG 793
FULL TERM NEONATE WITH MAJOR PROBLEMS
DRG 917
POISONING AND TOXIC EFFECTS OF DRUGS WITH MCC
DRG 918
POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MCC
Sibling Codes
T39.1X5D
Adverse effect of 4-Aminophenol derivatives, subsequent encounter
T39.1X5S
Adverse effect of 4-Aminophenol derivatives, sequela
Parent Sibling Codes
T39.1X1
Poisoning by 4-Aminophenol derivatives, accidental (unintentional)
T39.1X2
Poisoning by 4-Aminophenol derivatives, intentional self-harm
T39.1X3
Poisoning by 4-Aminophenol derivatives, assault
T39.1X4
Poisoning by 4-Aminophenol derivatives, undetermined
T39.1X5
Adverse effect of 4-Aminophenol derivatives
T39.1X6
Underdosing of 4-Aminophenol derivatives
Codes with Same Suffix
S06.1X5A
Traumatic cerebral edema with loss of consciousness greater than 24 hours with return to pre-existing conscious level, initial encounter
T36.1X5A
Adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter
T37.1X5A
Adverse effect of antimycobacterial drugs, initial encounter
T38.1X5A
Adverse effect of thyroid hormones and substitutes, initial encounter
T41.1X5A
Adverse effect of intravenous anesthetics, initial encounter
T42.1X5A
Adverse effect of iminostilbenes, initial encounter
T43.1X5A
Adverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter
T44.1X5A
Adverse effect of other parasympathomimetics [cholinergics], initial encounter
T45.1X5A
Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
T46.1X5A
Adverse effect of calcium-channel blockers, initial encounter
T47.1X5A
Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
T48.1X5A
Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
T49.1X5A
Adverse effect of antipruritics, initial encounter
T50.1X5A
Adverse effect of loop [high-ceiling] diuretics, initial encounter
Loading ...